Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sex and the development of Alzheimer's disease
Christian J. Pike
Journal of Neuroscience Research (2016) Vol. 95, Iss. 1-2, pp. 671-680
Open Access | Times Cited: 361

Showing 1-25 of 361 citing articles:

Sex differences in Alzheimer disease — the gateway to precision medicine
Maria Teresa Ferretti, M. Florencia Iulita, Enrica Cavedo, et al.
Nature Reviews Neurology (2018) Vol. 14, Iss. 8, pp. 457-469
Closed Access | Times Cited: 734
Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches
Derek Kellar, Suzanne Craft
The Lancet Neurology (2020) Vol. 19, Iss. 9, pp. 758-766
Open Access | Times Cited: 594
Brain aging and neurodegeneration: from a mitochondrial point of view
Amandine Grimm, Anne Eckert
Journal of Neurochemistry (2017) Vol. 143, Iss. 4, pp. 418-431
Open Access | Times Cited: 489
Genetic insights into biological mechanisms governing human ovarian ageing
Katherine S. Ruth, Felix R. Day, Jazib Hussain, et al.
Nature (2021) Vol. 596, Iss. 7872, pp. 393-397
Open Access | Times Cited: 293
Pathological mechanisms and therapeutic strategies for Alzheimer’s disease
Kin Yip Tam, Yaojun Ju
Neural Regeneration Research (2021) Vol. 17, Iss. 3, pp. 543-543
Open Access | Times Cited: 256
Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease
Lin Jia, Juan C. Piña‐Crespo, Yonghe Li
Molecular Brain (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 226
Clinical Advances in Sex- and Gender-Informed Medicine to Improve the Health of All
Deborah Bartz, Tanuja Chitnis, Ursula B. Kaiser, et al.
JAMA Internal Medicine (2020) Vol. 180, Iss. 4, pp. 574-574
Closed Access | Times Cited: 170
Alzheimer’s pathogenic mechanisms and underlying sex difference
Donghui Zhu, Axel Montagne, Zhen Zhao
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 11, pp. 4907-4920
Open Access | Times Cited: 159
A second X chromosome contributes to resilience in a mouse model of Alzheimer’s disease
Emily Jane Davis, Lauren Broestl, Samira Abdulai-Saiku, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 558
Open Access | Times Cited: 143
The Effect of Estrogen Replacement Therapy on Alzheimer's Disease and Parkinson's Disease in Postmenopausal Women: A Meta-Analysis
Yujia Song, Shu-ran Li, Xiaowan Li, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 138
GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer’s disease
Joan Jiménez-Baladó, Teal S. Eich
Seminars in Cell and Developmental Biology (2021) Vol. 116, pp. 146-159
Open Access | Times Cited: 130
Sex Differences in Alzheimer’s Disease: Insights From the Multiomics Landscape
Lei Guo, Margaret B. Zhong, Larry Zhang, et al.
Biological Psychiatry (2021) Vol. 91, Iss. 1, pp. 61-71
Open Access | Times Cited: 128
Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
C. Kwon Kim, Yin Rui Lee, Lynnett Ong, et al.
Journal of Alzheimer s Disease (2022) Vol. 87, Iss. 1, pp. 83-100
Open Access | Times Cited: 124
Risks, Benefits, and Treatment Modalities of Menopausal Hormone Therapy: Current Concepts
Jaya Mehta, Juliana M. Kling, JoAnn E. Manson
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 116
Reimagining cholinergic therapy for Alzheimer’s disease
Ezio Giacobini, A. Claudio Cuello, Abraham Fisher
Brain (2022) Vol. 145, Iss. 7, pp. 2250-2275
Open Access | Times Cited: 109
Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer’s Disease (EPAD) cohort
Rasha N.M. Saleh, Michael Hornberger, Craig Ritchie, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 89
Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease
Marzia Perluigi, Fabio Di Domenico, D. Allan Butterfield
Physiological Reviews (2023) Vol. 104, Iss. 1, pp. 103-197
Closed Access | Times Cited: 75
Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
Rammohan V. Rao, Kaavya G. Subramaniam, Julie Gregory, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1659-1659
Open Access | Times Cited: 57
Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
Anne‐Cathrine S. Vogt, Gary T. Jennings, Mona O. Mohsen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3895-3895
Open Access | Times Cited: 52
Alzheimer’s disease and drug delivery across the blood–brain barrier: approaches and challenges
Iram Iqbal, Fatima Saqib, Zobia Mubarak, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 16
Comparative profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation
Erika Castillo, Julio Leon, Guianfranco Mazzei, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 144
Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study
Hanna Savolainen‐Peltonen, Päivi Rahkola‐Soisalo, Fabian Hoti, et al.
BMJ (2019), pp. l665-l665
Open Access | Times Cited: 144
Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies
Ralph N. Martins, Victor L. Villemagne, Hamid R. Sohrabi, et al.
Journal of Alzheimer s Disease (2018) Vol. 62, Iss. 3, pp. 965-992
Open Access | Times Cited: 120
Sex gap in aging and longevity: can sex chromosomes play a role?
Gabriel Marais, Jean‐Michel Gaillard, Cristina Vieira, et al.
Biology of Sex Differences (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 115
Neurobiochemical Cross-talk Between COVID-19 and Alzheimer’s Disease
Mohammad Azizur Rahman, Kamrul Islam, Saidur Rahman, et al.
Molecular Neurobiology (2020) Vol. 58, Iss. 3, pp. 1017-1023
Open Access | Times Cited: 111
Page 1 - Next Page

Scroll to top